INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2017

Saffron aqueous extract and crocin reduced appetite, dietary intake, and body composition measures in patients with coronary artery disease.

In an 8-week randomized, double-blind, placebo-controlled trial, 84 patients with coronary artery disease were assigned to receive daily supplements of 30 mg saffron aqueous extract (SAE), 30 mg crocin, or placebo. Decreases in BMI, waist circumference, and fat mass were significantly greater in the SAE group than the crocin group (P < 0.001). Both SAE and crocin led to significant decreases in energy and dietary intake (P < 0.001 and P = 0.046, respectively) and appetite (P < 0.001 and P = 0.029, respectively), while placebo showed no change. No significant differences were observed in lipid profile parameters at the end of the study.

Study type
Randomized, double-blind, placebo-controlled trial
Who was studied
84 patients with coronary artery disease aged 40 to 65 years
What was measured
Lipid profile, appetite, dietary intakes, anthropometric indices, and body composition

THE PAPER

Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease.

Abedimanesh N, Bathaie SZ, Abedimanesh S, Motlagh B, Separham A, Ostadrahimi A. J Cardiovasc Thorac Res, 2017.

PubMed 29391933 ↗DOI 10.1016/j.ajp.2015.10.012 ↗

Heart & arteriesNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.